Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. 1995

J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
Soroka Medical Center, Kupat Holim Sick Fund of the Histadrut, Beersheba, Israel.

OBJECTIVE Because they found in an earlier study that inositol, an important intracellular second-messenger precursor, was effective against depression in open and double-blind trials, the authors studied its effectiveness against panic disorder. METHODS Twenty-one patients with panic disorder with or without agoraphobia completed a double-blind, placebo-controlled, 4-week, random-assignment crossover treatment trial of 12 g/day of inositol. RESULTS The frequency and severity of panic attacks and the severity of agoraphobia declined significantly more after inositol than after placebo administration. Side effects were minimal. CONCLUSIONS The authors conclude that inositol's efficacy, the absence of significant side effects, and the fact that inositol is a natural component of the human diet make it a potentially attractive therapeutic for panic disorder.

UI MeSH Term Description Entries
D007294 Inositol An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction. Myoinositol,Chiro-Inositol,Mesoinositol,Chiro Inositol
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000379 Agoraphobia Obsessive, persistent, intense fear of places or situations from which escape might be difficult or embarrassing. Phobia, Crowds,Phobia, Open Spaces,Crowds Phobia,Open Spaces Phobia
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D016584 Panic Disorder A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait. Panic Attacks,Attack, Panic,Attacks, Panic,Disorder, Panic,Disorders, Panic,Panic Attack,Panic Disorders

Related Publications

J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
June 2001, Journal of clinical psychopharmacology,
J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
November 2003, The Journal of clinical psychiatry,
J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
October 2000, Journal of clinical psychopharmacology,
J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
January 1997, The American journal of medicine,
J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
September 2021, International clinical psychopharmacology,
J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
February 1991, The Journal of clinical psychiatry,
J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
December 2000, Arquivos de neuro-psiquiatria,
J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
March 2001, Neurology,
J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
January 1996, Psychopharmacology bulletin,
J Benjamin, and J Levine, and M Fux, and A Aviv, and D Levy, and R H Belmaker
November 1996, The British journal of psychiatry : the journal of mental science,
Copied contents to your clipboard!